JP2014532655A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532655A5
JP2014532655A5 JP2014539026A JP2014539026A JP2014532655A5 JP 2014532655 A5 JP2014532655 A5 JP 2014532655A5 JP 2014539026 A JP2014539026 A JP 2014539026A JP 2014539026 A JP2014539026 A JP 2014539026A JP 2014532655 A5 JP2014532655 A5 JP 2014532655A5
Authority
JP
Japan
Prior art keywords
acoustic energy
nanosuspension
frequency
hertz
prepared according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014539026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532655A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/062026 external-priority patent/WO2013066735A1/en
Publication of JP2014532655A publication Critical patent/JP2014532655A/ja
Publication of JP2014532655A5 publication Critical patent/JP2014532655A5/ja
Pending legal-status Critical Current

Links

JP2014539026A 2011-10-31 2012-10-26 ナノ懸濁過程 Pending JP2014532655A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161553508P 2011-10-31 2011-10-31
US61/553,508 2011-10-31
PCT/US2012/062026 WO2013066735A1 (en) 2011-10-31 2012-10-26 Nano-suspension process

Publications (2)

Publication Number Publication Date
JP2014532655A JP2014532655A (ja) 2014-12-08
JP2014532655A5 true JP2014532655A5 (enExample) 2015-11-19

Family

ID=48192642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539026A Pending JP2014532655A (ja) 2011-10-31 2012-10-26 ナノ懸濁過程

Country Status (6)

Country Link
US (1) US9381518B2 (enExample)
EP (1) EP2773323A4 (enExample)
JP (1) JP2014532655A (enExample)
AU (1) AU2012332894A1 (enExample)
CA (1) CA2853470A1 (enExample)
WO (1) WO2013066735A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015094927A1 (en) * 2013-12-17 2015-06-25 Merck Sharp & Dohme Corp. Media milling process for the manufacture of active pharmaceutical ingredients in propellants
WO2017087897A1 (en) * 2015-11-18 2017-05-26 Arytha Biosciences, Llc Processes and systems for preparing cellular or viral membranes and nanoparticles
JP6667651B2 (ja) * 2016-09-30 2020-03-18 富士フイルム株式会社 分散物の製造方法、及びインクジェット記録方法
WO2019040346A1 (en) * 2017-08-25 2019-02-28 Merck Sharp & Dohme Corp. METHODS FOR PREPARING STORED AMORPHOUS MEDICATION FORMULATIONS USING ACOUSTIC FUSION
US12285731B2 (en) 2019-09-12 2025-04-29 United States Of America, As Represented By The Secretary Of The Army Acoustic mixing system for creating propellant mixture
WO2025096329A1 (en) * 2023-10-31 2025-05-08 Genentech, Inc. Method for preparing stable peptide nanoparticle formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552160A (en) * 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
US5591456A (en) * 1995-02-10 1997-01-07 Nanosystems L.L.C. Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
RU2186562C2 (ru) * 1996-08-22 2002-08-10 Ресеч Трайангл Фармасьютикалс Лтд. Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
GB2339703B (en) 1998-07-22 2002-05-01 Univ Cardiff Particle manipulation device
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
AU2003263024A1 (en) * 2002-04-23 2003-11-10 Christopher Mcconville Process of forming and modifying particles and compositions produced thereby
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7188993B1 (en) * 2003-01-27 2007-03-13 Harold W Howe Apparatus and method for resonant-vibratory mixing
GB0302671D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US20060086834A1 (en) 2003-07-29 2006-04-27 Robert Pfeffer System and method for nanoparticle and nanoagglomerate fluidization
US7541166B2 (en) * 2003-09-19 2009-06-02 Microfluidic Systems, Inc. Sonication to selectively lyse different cell types
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
CA2587276A1 (en) 2004-11-08 2006-05-18 Baxter International Inc. Nanoparticulate compositions of tubulin inhibitor compounds
US20060134646A1 (en) 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
AU2005326168A1 (en) * 2004-12-21 2006-08-03 Baxter Healthcare S.A. (polyalkoxy)sulfonate surface modifiers
CA2603189A1 (en) * 2005-04-13 2006-10-19 Pfizer Products Inc. Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles
DE102005057333B4 (de) 2005-11-28 2008-11-20 Dr. Hielscher Gmbh Verfahren und Vorrichtungen zur Beschallung von Flüssigkeiten mit Niederfrequenz-Leistungs-Ultraschall
US20110163469A1 (en) * 2005-12-16 2011-07-07 Massachusetts Institute Of Technology High-throughput fabrication of microparticles
US20080033296A1 (en) 2006-02-17 2008-02-07 Florida Gulf Coast University Methods for delivering materials into biological systems using sonic energy
TW200920347A (en) * 2007-07-16 2009-05-16 Poniard Pharmaceuticals Inc Oral formulations for picoplatin
EP2262898B1 (en) 2008-03-07 2018-01-24 Regeneron Pharmaceuticals, Inc. Es cell-derived mice from diploid host embryo injection
US20110223216A1 (en) 2008-11-17 2011-09-15 Wayne State University Nanoparticles and Porous Particles and Methods of Making the Same

Similar Documents

Publication Publication Date Title
Paudel et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations
Thorat et al. Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective
JP2014061009A5 (enExample)
CN109963555A (zh) 一种包含美洛昔康的可注射的药物组合物及其制备方法
Bell et al. Advances in integrative nanomedicine for improving infectious disease treatment in public health
CY1121241T1 (el) Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων
AU2018253545A1 (en) Microcrystalline diketopiperazine compositions and methods
WO2014193716A3 (en) Capsid-modified, raav3 vector compositions and uses in gene therapy of human liver cancer
WO2014014613A3 (en) Self-assembling peptides, peptide nanostructures and uses thereof
WO2015152693A3 (ko) 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물
MY207375A (en) Finasteride polymeric nanoparticle, aqueous suspension containing the same, composition for the treatment of alopecia, process of preparation of said composition, and its use
WO2019090030A8 (en) Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations
WO2013132457A3 (en) Nanocrystalline solid dispersion compositions and process of preparation thereof
Zhu et al. The induction of maturation on dendritic cells by TiO2 and Fe3O4@ TiO2 nanoparticles via NF-κB signaling pathway
Floris et al. Cavitation effect on chitosan nanoparticle size: A possible approach to protect drugs from ultrasonic stress
WO2014152782A3 (en) Substantially surfactant-free, submicron dispersions of hydrophobic agents containing high levels of water miscible solvent
MX2015003717A (es) Polipeptidos del virus de chikungunya que expresan el virus de sarampion recombinante y sus aplicaciones.
RU2014148544A (ru) Составы на основе полиинозиновой-полицитидиловой кислоты (poly(i:с)) для лечения инфекций верхних дыхательных путей
WO2015053857A3 (en) Efficient collection of nanoparticles
CY1124635T1 (el) Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα
WO2017103600A8 (en) Preparation of respirable zafirlukast particles
WO2013025442A3 (en) Concentrated felbamate formulations for parenteral administration
WO2017036916A8 (en) Process to manufacture cross-linked enzyme aggregates
MX2016000021A (es) Sirna virus especifico del dengue, estructura arn oligo helicoidal, y composicion para la supresion de proliferacion del virus del dengue que comprende la estructura arn.
Mansour et al. Lipid nanoparticulate drug delivery and nanomedicine